Givaudan, CH0010645932

Givaudan reports CHF 5.89 billion sales: target for Givaudan stock is CHF 3,850

Published on 10/14/2026 at 10:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fragrance and Beauty sales grew 8.80 percent like-for-like in the first nine months. Givaudan stock trades at EUR 4,105.50 on October 14, 2026.

Sales and analyst targets

  • Givaudan recorded CHF 5.89 billion in sales during the first nine months of 2026.
  • Fragrance and Beauty sales increased 8.80 percent like-for-like in the same period.
  • Givaudan stock trades at EUR 4,105.50 at 10:00 a.m. CEST on October 14, 2026.
  • Barclays set a CHF 3,850 target on October 5, 2026.
Architectural photography of a modern research and development building. A sweeping glass-curtain-wall wing reflects an overcast sky. A curved stone pathway winds through a landscaped garden with flowering lavender, rosemary, and aromatic shrubs. White co
Givaudan CH0010645932 modernes Forschungs- und Entwicklungszentrum mit geschwungener Glasfassade und aromatischem Duftpflanzen-Garten, Illustration mit AI erstellt.

Givaudan (ISIN CH0010645932) reported CHF 5.89 billion in sales for the first nine months of 2026, up 5.20 percent on a like-for-like basis and 2.60 percent in Swiss francs. The company released the figures on October 13, 2026, while Barclays had raised its target from CHF 3,450 to CHF 3,850 on October 5, 2026, according to Givaudan and Markets Insider.

Three dated developments

On October 5, 2026, Barclays upgraded Givaudan to Overweight and lifted its target to CHF 3,850 from CHF 3,450, according to Markets Insider. On October 13, 2026, Jefferies maintained a Hold rating with a CHF 3,030 target, as reported by Markets Insider. Givaudan then reported CHF 5.89 billion in nine-month sales on October 13, 2026, making the operating update the latest dated development.

What drives the sales mix?

Fragrance and Beauty generated CHF 3.15 billion in the first nine months, up 8.80 percent like-for-like and 7.80 percent in Swiss francs, according to Givaudan. Fine Fragrance sales increased 15.30 percent like-for-like, while Consumer Products rose 9.30 percent, giving the fragrance division a clear lead over Taste and Wellbeing.

Taste and Wellbeing sales reached CHF 2.74 billion, with like-for-like growth of 1.50 percent and a 2.80 percent decline in Swiss francs. North America declined 3.30 percent like-for-like, and the company linked the pressure to weakness in its Health and Functional business unit and tariff refunds made to customers in the third quarter.

Next results date

Givaudan scheduled its full-year 2026 results for January 27, 2027, according to Givaudan. Its 2030 strategy targets average like-for-like sales growth of 4 to 6 percent and adjusted free cash flow above 12 percent over the five-year period.

Stock price in trading

At Lang & Schwarz, Givaudan stock was trading at EUR 4,105.50 on October 14, 2026 at 10:00 a.m. CEST. On SIX, the stock was at CHF 3,840 at 9:46 a.m. CEST on October 14, 2026, against a 52-week range of CHF 2,566 to CHF 3,857; market capitalization was CHF 35.4 billion at that time.

The further course of trading is shown by the continuously updated real-time quote of Givaudan stock.

Givaudan stock facts

  • Company: Givaudan S.A.
  • ISIN: CH0010645932
  • Ticker: GIVN.SW
  • Primary exchange: SIX Swiss Exchange
  • Price Lang & Schwarz as of October 14, 2026, 10:00 a.m. CEST: EUR 4,105.50
  • Market capitalization: CHF 35.4 billion as of October 14, 2026
  • 52-week range: CHF 2,566.00-CHF 3,857.00 as of October 14, 2026
  • Sector / Industry: Materials / specialty chemicals
  • Next earnings date: January 27, 2027

Market context: Market report SMI.

More news and analyses on Givaudan stock

Disclaimer...

en | CH0010645932 | GIVAUDAN | boerse | 70322204 | bgmi